Zhongzhi Pharmaceutical Holdings Limited (3737.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2577
First IPO Date
July 13, 2015
| Name | Title | Pay | Year Born |
| Ying Sheng Lai | Chief Financial Officer & Executive Director | 1.59M | 1994 |
| Xiao Jun Cao | Deputy GM & Executive Director | 1.8M | 1968 |
| Ying Feng Lai | Chief Executive & Executive Director | 2.79M | 1992 |
| Zhi Tian Lai | Executive Chairman | 3.42M | 1968 |
| Wing Yan | Company Secretary | 0 | 1982 |
Zhongzhi Pharmaceutical Holdings Limited, an investment holding firm based in the People's Republic of China, focuses on the entire lifecycle of pharmaceutical products, from research and development to manufacturing and distribution. Its operations are structured across three main divisions: pharmaceutical production, management of its physical retail pharmacy chain, and its online pharmacy platform. The company offers Chinese patent medicines and traditional Chinese decoction pieces, marketed under prominent brands such as Zeus, Liumian, and Caojinghua. In addition to its core pharmaceutical activities, Zhongzhi also produces and sells food products and traditional Chinese herbs, manages properties, and offers detection and testing services. By the end of 2021, the company managed a network of 398 self-owned retail pharmacies. Of these, 361 were approved for medical insurance payments and are situated in Zhongshan, Guangdong Province, operating under the Zeus brand. Established in 1993, the company's headquarters are also located in Zhongshan, PRC. Crystal Talent Investment Group Limited holds a controlling stake in Zhongzhi Pharmaceutical Holdings Limited.